Literature DB >> 15721277

Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.

Qiang Zhu1, Haiyan Chang, Yan Chen, Fang Fang, Changyong Xue, Fenghua Zhang, Meizhen Qiu, Hanzhong Wang, Bin Wang, Ze Chen.   

Abstract

Influenza virus infection frequently causes complications and some excess mortality in the patients with diabetes. Vaccination is an effective measure to prevent influenza virus infection. In this paper, antibody response and protection against influenza virus infection induced by vaccination were studied in mouse model of diabetes. Healthy and diabetic BALB/c mice were immunized once or twice with inactivated influenza virus vaccine at various dosages. Four weeks after the first immunization or 1 week after the second immunization, the mice were challenged with influenza virus at a lethal dose. The result showed that the antibody responses in diabetic mice were inhibited. Immunization once with high dose or twice with low dose of vaccine provided full protection against lethal influenza virus challenge in diabetic mice, however, in healthy mice, immunization only once with low dose provided a full protection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721277     DOI: 10.1016/j.bbrc.2005.01.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice.

Authors:  Wenting Xu; Mei Zheng; Feng Zhou; Ze Chen
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

2.  Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.

Authors:  Mei Zheng; Fen Liu; Yiqing Shen; Shilei Wang; Wenting Xu; Fang Fang; Bing Sun; Zhenyuan Xie; Ze Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model.

Authors:  Abbas Jamali; Farzaneh Sabahi; Taravat Bamdad; Hamidreza Hashemi; Fereidoun Mahboudi; Masume Tavasoti Kheiri
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

4.  Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model.

Authors:  Mei Zheng; Di Qu; Haiming Wang; Zhiping Sun; Xueying Liu; Jianjun Chen; Changgui Li; Xuguang Li; Ze Chen
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

5.  Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?

Authors:  Katina D Hulme; Linda A Gallo; Kirsty R Short
Journal:  Front Microbiol       Date:  2017-05-22       Impact factor: 5.640

6.  Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening.

Authors:  Fen Liu; Xueliang Wang; Mei Zheng; Feifei Xiong; Xueying Liu; Linting Zhou; Wensong Tan; Ze Chen
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

Review 7.  Respiratory Tract Infections in Diabetes - Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity.

Authors:  Amnah Al-Sayyar; Katina D Hulme; Ronan Thibaut; Jagadeesh Bayry; Frederick J Sheedy; Kirsty R Short; Fawaz Alzaid
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.